Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Chen, Huan  [Clear All Filters]
Journal Article
Mo X-D, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, Wang J-Z, et al. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation in First Complete Remission Can Abrogate the Poor Outcomes of Children with Acute Myeloid Leukemia Resistant to the First Course of Induction Chemotherapy. Biol Blood Marrow Transplant. 2016.
Fu H, Lv M, Liu H, Sun Y, Zhang Y, Mo X, Han T, Wang F, Yan C, Wang Y, et al. Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation. Bone Marrow Transplant. 2023.
Tang D, Liu M, Gao S, Sun H, Peng Y, Li Y, Wang Y, Wang X, Chen H. Thermally engineered MSC-derived extracellular vesicles ameliorate colitis in mice by restoring the imbalanced Th17/Treg cell ratio. Int Immunopharmacol. 2023;125(Pt A):111077.
Cao L-Q, Zhou J-R, Zhang X-H, Xu L-P, Wang Y, Chen Y-H, Chen H, Chen Y, Han W, Yan C-H, et al. A scoring system for predicting the prognosis of late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther. 2021.
Ma R, Zhu D-P, Zhang X-H, Xu L-P, Wang Y, Mo X-D, Lv M, Zhang Y-Y, Cheng Y-F, Yan C-H, et al. Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience. Bone Marrow Transplant. 2024.
Chen H, Xu L-P, Zhang X-H, Wang Y, Chen Y-H, Yan C-H, Cheng Y-F, Han W, Chen Y, Qin Y-Z, et al. Safety and outcomes of maintenance therapy with third-generation tyrosine kinase inhibitor after allogeneic hematopoietic cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia patients with T315I mutation. Leuk Res. 2022;121:106930.
Chang Y-J, Xu L-P, Wang Y, Zhang X-H, Chen H, Chen Y-H, Wang F-R, Han W, Sun Y-Q, Yan C-H, et al. Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody. Bone Marrow Transplant. 2020.
Chen Y, Xu L-P, Liu K-Y, Chen H, Chen Y-H, Zhang X-H, Wang Y, Wang F-R, Han W, Wang J-Z, et al. Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus. J Clin Virol. 2015;75:10-15.
Fu H, Zhao J, Xu L, Liu K, Wang Y, Chen H, Han W, Wang J, Wang F, Huang X, et al. Reduced β2-GPI is associated with increased platelet aggregation and activation in patients with prolonged isolated thrombocytopenia after allo-HSCT. Sci China Life Sci. 2019.
Zhang X-H, Wang G-X, Zhu H-H, Liu Y-R, Xu L-P, Han W, Chen H, Chen Y-H, Wang F-R, Wang J-Z, et al. Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2015.
Zhang W, Sun Y, Bai L, Zhi L, Yang Y, Zhao Q, Chen C, Qi Y, Gao W, He W, et al. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11. J Clin Invest. 2021.
Wang X-Y, Fan Q-Z, Xu L-P, Wang Y, Zhang X-H, Chen H, Chen Y-H, Wang F-R, Han W, Sun Y-Q, et al. The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia. Cytometry B Clin Cytom. 2019.
Xiao M, Zhou J, Zhu X, He Y, Wang F, Zhang Y, Mo X, Han W, Wang J, Wang Y, et al. A prognostic score system in adult T-cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2024.
Zhao P, Wu Y, He Y, Chong S, Qu Q, Deng R, Sun X, Huang Q-S, Liu X, Zhu X, et al. A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy. Blood Adv. 2021.
Huang Q-S, Han T-X, Fu H-X, Meng H, Zhao P, Wu Y-J, He Y, Zhu X-L, Wang F-R, Zhang Y-Y, et al. Prognostic factors and outcomes in patients with septic shock after allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther. 2023.
Liu S-N, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, Wang J-Z, et al. Prognostic factors and long-term follow-up of basiliximab for steroid-refractory acute GVHD: updated experienced from a large-scale study. Am J Hematol. 2020.
Bai L, Cheng Y-F, Lu A-D, Suo P, Wang Y, Zuo Y-X, Yan C-H, Wu J, Jia Y-P, Sun Y-Q, et al. Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia. Leuk Res. 2020;91:106333.
Huo M-R, Xu Y-J, Zhai S-Z, Lv M, Wang Y, Cao L-Q, Xu L-P, Zhang X-H, Chen H, Chen Y-H, et al. Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study. Hum Immunol. 2018.
Feng C-J, Zhao P, Fu H-X, Yan C-H, Wang C-C, Zhu X-L, He Y, Wang F-R, Zhang Y-Y, Mo X-D, et al. A predictive model of herpes zoster after allogeneic hematopoietic stem cell transplantation: VZV reactivation following antiviral prophylaxis discontinuation. Am J Hematol. 2023.
Sun X, Fu H, Wang C, Zhang Y, Han W, Chen H, Wang Y, Chen Q, He Y, Huang Q, et al. Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infection. Bone Marrow Transplant. 2022.
Wu Y-J, Liu H-X, Zhu X-L, Fu H-X, He Y, Wang F-R, Zhang Y-Y, Mo X-D, Han W, Wang J-Z, et al. Predicting short-term and long-term mortalities from sepsis in patients who receive allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2023.
Chen Q, Zhao X, Fu H-X, Chen Y-H, Zhang Y-Y, Wang J-Z, Wang Y, Wang F-R, Mo X-D, Han W, et al. Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplant. 2020.
Hu L, Wang Q, Zhang X, Xu L, Wang Y, Yan C, Chen H, Chen Y, Liu K, Wang H, et al. Positive stool culture could predict the clinical outcomes of haploidentical hematopoietic stem cell transplantation. Front Med. 2019.
Cao L-Q, Huo W-X, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, et al. Peripheral blood stem cell transplantation from haploidentical related donor could achieve satisfactory clinical outcomes for intermediate- or high-risk adult acute myeloid leukemia patients. Bone Marrow Transplant. 2023.
Liu J, Kong J, Chang YJun, Chen H, Chen YHong, Han W, Wang Y, Yan CHua, Wang JZhi, Wang FRong, et al. Patients with refractory CMV infection following allo-HSCT are at high risk for CMV disease and non-relapse mortality. Clin Microbiol Infect. 2015.

Pages